Articles related to Family Medicine/General Practice

Lymphedema and lipedema, while superficially similar, have distinct pathophysiologies and management strategies. Understanding these differences is essential for providing targeted care and improving patient outcomes.

SGLT-2 inhibitors offer benefits beyond glucose control, potentially addressing the systemic inflammatory components of metabolic diseases like diabetes, heart failure, and gout.

Patients taking semaglutide for diabetes were more than four times more likely to develop NAION compared to those on other diabetes medications, while those using it for obesity had a seven-fold increased risk.

Rapid weight loss from semaglutide use can lead to breast ptosis, mirroring effects seen after bariatric surgery. Healthcare providers should be prepared to counsel patients on this potential outcome and offer strategies for management.

Varicose veins result from elevated venous pressure due to incompetent valves, obstruction, or a combination of both, leading to impaired venous return in the lower extremities.

This target trial emulation study provides critical insights into weight change associated with eight first-line antidepressants, emphasizing the minimal weight gain with bupropion. Clinicians should integrate these findings into treatment decisions to address patient concerns about weight gain.